List of Tables
Table 1. Global Drugs for PrEP Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drugs for PrEP Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drugs for PrEP Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drugs for PrEP Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drugs for PrEP Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drugs for PrEP Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drugs for PrEP Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drugs for PrEP Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drugs for PrEP, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drugs for PrEP, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drugs for PrEP, Product Types and Applications
Table 12. Global Key Manufacturers of Drugs for PrEP, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs for PrEP Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drugs for PrEP Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs for PrEP Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drugs for PrEP Sales by Region (K Units), 2021–2026
Table 18. Global Drugs for PrEP Sales Market Share by Region (2021–2026)
Table 19. Global Drugs for PrEP Sales by Region (K Units), 2027–2032
Table 20. Global Drugs for PrEP Sales Market Share by Region (2027–2032)
Table 21. Global Drugs for PrEP Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drugs for PrEP Revenue Market Share by Region (2021–2026)
Table 23. Global Drugs for PrEP Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drugs for PrEP Revenue Market Share by Region (2027–2032)
Table 25. North America Drugs for PrEP Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drugs for PrEP Sales by Country (K Units), 2021–2026
Table 27. North America Drugs for PrEP Sales by Country (K Units), 2027–2032
Table 28. North America Drugs for PrEP Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drugs for PrEP Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drugs for PrEP Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drugs for PrEP Sales by Country (K Units), 2021–2026
Table 32. Europe Drugs for PrEP Sales by Country (K Units), 2027–2032
Table 33. Europe Drugs for PrEP Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drugs for PrEP Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drugs for PrEP Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drugs for PrEP Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drugs for PrEP Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drugs for PrEP Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drugs for PrEP Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drugs for PrEP Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drugs for PrEP Sales by Country (K Units), 2021–2026
Table 42. Latin America Drugs for PrEP Sales by Country (K Units), 2027–2032
Table 43. Latin America Drugs for PrEP Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drugs for PrEP Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drugs for PrEP Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drugs for PrEP Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drugs for PrEP Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drugs for PrEP Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drugs for PrEP Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drugs for PrEP Sales (K Units) by Type (2021–2026)
Table 51. Global Drugs for PrEP Sales (K Units) by Type (2027–2032)
Table 52. Global Drugs for PrEP Sales Market Share by Type (2021–2026)
Table 53. Global Drugs for PrEP Sales Market Share by Type (2027–2032)
Table 54. Global Drugs for PrEP Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drugs for PrEP Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drugs for PrEP Revenue Market Share by Type (2021–2026)
Table 57. Global Drugs for PrEP Revenue Market Share by Type (2027–2032)
Table 58. Global Drugs for PrEP Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drugs for PrEP Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drugs for PrEP Sales (K Units) by Application (2021–2026)
Table 61. Global Drugs for PrEP Sales (K Units) by Application (2027–2032)
Table 62. Global Drugs for PrEP Sales Market Share by Application (2021–2026)
Table 63. Global Drugs for PrEP Sales Market Share by Application (2027–2032)
Table 64. Global Drugs for PrEP Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drugs for PrEP Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drugs for PrEP Revenue Market Share by Application (2021–2026)
Table 67. Global Drugs for PrEP Revenue Market Share by Application (2027–2032)
Table 68. Global Drugs for PrEP Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drugs for PrEP Price (US$/Unit) by Application (2027–2032)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Gilead Sciences Drugs for PrEP Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. ViiV Healthcare Company Information
Table 76. ViiV Healthcare Description and Business Overview
Table 77. ViiV Healthcare Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. ViiV Healthcare Drugs for PrEP Product
Table 79. ViiV Healthcare Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Drugs for PrEP Product
Table 84. Teva Recent Developments/Updates
Table 85. Amneal Pharmaceuticals Company Information
Table 86. Amneal Pharmaceuticals Description and Business Overview
Table 87. Amneal Pharmaceuticals Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Amneal Pharmaceuticals Drugs for PrEP Product
Table 89. Amneal Pharmaceuticals Recent Developments/Updates
Table 90. Aurobindo Pharma Company Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Aurobindo Pharma Drugs for PrEP Product
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. Mylan Company Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Mylan Drugs for PrEP Product
Table 99. Mylan Recent Developments/Updates
Table 100. Zydus Company Information
Table 101. Zydus Description and Business Overview
Table 102. Zydus Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Zydus Drugs for PrEP Product
Table 104. Zydus Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Qilu Pharmaceutical Drugs for PrEP Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Anhui Baker Biopharmaceutical Company Information
Table 111. Anhui Baker Biopharmaceutical Description and Business Overview
Table 112. Anhui Baker Biopharmaceutical Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Anhui Baker Biopharmaceutical Drugs for PrEP Product
Table 114. Anhui Baker Biopharmaceutical Recent Developments/Updates
Table 115. Chengdu Brilliant Pharmaceutical Company Information
Table 116. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 117. Chengdu Brilliant Pharmaceutical Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chengdu Brilliant Pharmaceutical Drugs for PrEP Product
Table 119. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 120. North China Pharmaceutical Company Information
Table 121. North China Pharmaceutical Description and Business Overview
Table 122. North China Pharmaceutical Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. North China Pharmaceutical Drugs for PrEP Product
Table 124. North China Pharmaceutical Recent Developments/Updates
Table 125. Chia Tai Tianqing Pharmaceutical Company Information
Table 126. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 127. Chia Tai Tianqing Pharmaceutical Drugs for PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Chia Tai Tianqing Pharmaceutical Drugs for PrEP Product
Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Drugs for PrEP Distributors List
Table 133. Drugs for PrEP Customers List
Table 134. Drugs for PrEP Market Trends
Table 135. Drugs for PrEP Market Drivers
Table 136. Drugs for PrEP Market Challenges
Table 137. Drugs for PrEP Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs for PrEP
Figure 2. Global Drugs for PrEP Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drugs for PrEP Market Share by Type: 2025 & 2032
Figure 4. Oral Drugs Product Picture
Figure 5. Injections Product Picture
Figure 6. Global Drugs for PrEP Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Drugs for PrEP Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Drugs for PrEP Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drugs for PrEP Market Size (US$ Million), 2021–2032
Figure 13. Global Drugs for PrEP Sales (K Units), 2021–2032
Figure 14. Global Drugs for PrEP Average Price (US$/Unit), 2021–2032
Figure 15. Drugs for PrEP Report Years Considered
Figure 16. Drugs for PrEP Sales Share by Manufacturers in 2025
Figure 17. Global Drugs for PrEP Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Drugs for PrEP Players: Market Share by Revenue in Drugs for PrEP in 2025
Figure 19. Drugs for PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Drugs for PrEP Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Drugs for PrEP Sales Market Share by Country (2021–2032)
Figure 22. North America Drugs for PrEP Revenue Market Share by Country (2021–2032)
Figure 23. United States Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Drugs for PrEP Sales Market Share by Country (2021–2032)
Figure 26. Europe Drugs for PrEP Revenue Market Share by Country (2021–2032)
Figure 27. Germany Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Drugs for PrEP Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Drugs for PrEP Revenue Market Share by Region (2021–2032)
Figure 34. China Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Drugs for PrEP Sales Market Share by Country (2021–2032)
Figure 42. Latin America Drugs for PrEP Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Drugs for PrEP Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Drugs for PrEP Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Drugs for PrEP Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Drugs for PrEP by Type (2021–2032)
Figure 53. Global Revenue Market Share of Drugs for PrEP by Type (2021–2032)
Figure 54. Global Drugs for PrEP Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Drugs for PrEP by Application (2021–2032)
Figure 56. Global Revenue Market Share of Drugs for PrEP by Application (2021–2032)
Figure 57. Global Drugs for PrEP Price (US$/Unit) by Application (2021–2032)
Figure 58. Drugs for PrEP Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
